Trial intelligence / Profile preview

VIDEO: Ozurdex vs Aflibercept in DME

NCT05990829Phase 4Unknown

Sponsor
Tianjin Medical University Eye Hospital
Start
Oct 2023
Primary completion
Oct 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dexamethasone in diabetic macular edema (DME), sponsored by Tianjin Medical University Eye Hospital. Status: unknown.

02

Drugs

dexamethasone
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT05990829.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05990829.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call